Innovating Works

FUNDACION PRIVADA DE LUCHA CONTRA EL SIDA

Activa
RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 HIPRA SCIENTIFIC tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine against different variants of COVID-...
2021-11-12 - 2024-05-31 | Financiado
Trep-AB: Repurposing clinically approved antibacterial drugs for treponematoses therapy FUNDACION PRIVADA DE LUCHA CONTRA EL SIDA tramitó un H2020: ERC-2019-STG Current therapeutic options for human treponematoses, syphilis and yaws, are, broadly speaking, restricted to one antibiotic: injectable pen...
2020-01-29 - 2025-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.